Key result
Selective serotonin reuptake inhibitors such as citalopram, sertraline, and paroxetine are associated with adverse cardiac effects including QT prolongation, mitral regurgitation, and cardiotoxicity.
Answers are grounded in this paper and cite their sources.
This commentary highlights the potential cardiotoxic effects of specific SSRIs (citalopram, sertraline, and paroxetine) in patients treated for depression, emphasizing the need for careful evaluation and monitoring.
Selective serotonin reuptake inhibitors (SSRIs) are the most common antidepressants used to treat depression. However, they can adversely affect the heart. Three SSRIs in particular cause cardiac problems: Citalopram, Sertraline, and Paroxetine. Citalopram can alter signals to the heart’s natural pacemaker, which is located in the upper wall of the right atrium. Sertraline can lower serotonin activity in the mitral valve. Paroxetine can cause lower recovery rate from a heart attack. Certain drugs must be evaluated more to determine if it is suitable to be prescribed to treat depression.
No takes yet. Share an insight, caveat, or question.
Kelsee Frisbie (2026) conducted an editorial in Depression. Selective serotonin reuptake inhibitors (citalopram, sertraline, paroxetine) was evaluated on Cardiovascular adverse effects. Selective serotonin reuptake inhibitors such as citalopram, sertraline, and paroxetine are associated with adverse cardiac effects including QT prolongation, mitral regurgitation, and cardiotoxicity.
Synapse has enriched 10 related papers. Consider them for comparative context: